These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31753465)

  • 1. Waterlining of Methamphetamine.
    Lowder KN; Caplan JP
    Psychosomatics; 2020; 61(1):103-104. PubMed ID: 31753465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surgical treatment, with repair of the nasal pyramid, in bilateral dacryocystitis in a patient with facial injuries].
    Olteanu M; Cupşa V; Olteanu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(2):137-41. PubMed ID: 133409
    [No Abstract]   [Full Text] [Related]  

  • 3. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on Marshall et al. (2010): are long-term negative health consequences of methamphetamine use important to youth?
    Rawson RA; Gonzales R
    Addiction; 2010 Jun; 105(6):1003-4. PubMed ID: 20659060
    [No Abstract]   [Full Text] [Related]  

  • 5. Crystalline retinopathy from nasal ingestion of methamphetamine.
    Kumar RL; Kaiser PK; Lee MS
    Retina; 2006 Sep; 26(7):823-4. PubMed ID: 16963858
    [No Abstract]   [Full Text] [Related]  

  • 6. Facial emphysema following nasal fracture.
    Kurunadalingam H; Beegun I; Dubrey SW
    Br J Hosp Med (Lond); 2015 Feb; 76(2):113. PubMed ID: 25671480
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
    Kirkpatrick MG; Gunderson EW; Johanson CE; Levin FR; Foltin RW; Hart CL
    Addiction; 2012 Apr; 107(4):783-91. PubMed ID: 22050030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meth mouth severity in response to drug-use patterns and dental access in methamphetamine users.
    Brown RE; Morisky DE; Silverstein SJ
    J Calif Dent Assoc; 2013 Jun; 41(6):421-8. PubMed ID: 23875434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe post-traumatic epistaxis].
    Guerrier Y; Dejean Y; Guerrier B; Sultana B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Jun; 24(6):461-2. PubMed ID: 126295
    [No Abstract]   [Full Text] [Related]  

  • 11. [Driving under the influence of amphetamine and metamphetamine].
    Lia K; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methamphetamine epidemic: implications for HIV prevention and treatment.
    Colfax G; Shoptaw S
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):194-9. PubMed ID: 16343378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR
    Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK; Beste C
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intranasal methamphetamine on metacognition of agency.
    Kirkpatrick MG; Metcalfe J; Greene MJ; Hart CL
    Psychopharmacology (Berl); 2008 Mar; 197(1):137-44. PubMed ID: 18043908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.
    Newmeyer MN; Concheiro M; da Costa JL; Flegel R; Gorelick DA; Huestis MA
    Drug Test Anal; 2015 Oct; 7(10):877-83. PubMed ID: 25786659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pott puffy tumor associated with intranasal methamphetamine.
    Banooni P; Rickman LS; Ward DM
    JAMA; 2000 Mar; 283(10):1293. PubMed ID: 10714727
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
    Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
    Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory study on association between family relationship and relapse among methamphetamine users in Compulsory Treatment System of Khon Kaen and Yasothon Provinces.
    Rodseeda P; Ratanasiri A; Kanato M; Pinitsoontorn S; Chiawiriyabunya I
    J Med Assoc Thai; 2010 Mar; 93 Suppl 3():S1-5. PubMed ID: 21302405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.
    Mravčík V; Skařupová K; Orlíková B; Zábranský T; Karachaliou K; Schulte B
    Int J Drug Policy; 2011 Mar; 22(2):172-3. PubMed ID: 21242079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.